OGN
OGN (osteoglycin, also known as mimecan, OIF and SLRP3A) is a secreted small leucine-rich proteoglycan of the extracellular matrix. It induces bone formation in conjunction with TGF-beta-1 or TGF-beta-2 and may regulate osteoblast differentiation. Browse Assay Genie's current range of OGN research reagents below, or read on for the biology behind the target.
OGN, also called mimecan, is an extracellular matrix protein best characterised for its role in bone biology. The annotated function of the OGN protein is to induce bone formation in conjunction with TGF-beta-1 or TGF-beta-2. The NCBI Gene summary describes it as inducing ectopic bone formation together with transforming growth factor beta, and notes that it may regulate osteoblast differentiation.
The OGN gene encodes a member of the small leucine-rich proteoglycan (SLRP) family, and UniProt places the protein in SLRP class III. HGNC lists it in the group of small leucine rich proteoglycans. The protein is secreted into the extracellular space and extracellular matrix. Alternative splicing of the gene results in multiple transcript variants. The mouse ortholog is designated Ogn.
The name osteoglycin, and the alias OIF, reflect the original description of the protein as an osteoinductive factor, which is the previous name recorded by HGNC. Other aliases include mimecan and SLRP3A. Beyond bone, the NCBI Gene summary reports that high expression of the encoded protein may be associated with elevated heart left ventricular mass, which makes OGN of interest in cardiac as well as skeletal research.
OGN induces bone formation in conjunction with TGF-beta-1 or TGF-beta-2, making it a relevant factor in studies of osteoinduction.
The protein may regulate osteoblast differentiation, so it is studied in work on how bone-forming cells mature.
As a secreted SLRP class III proteoglycan in the extracellular matrix, OGN is a subject in studies of matrix composition and function.
High OGN expression may be associated with elevated heart left ventricular mass, prompting investigation in cardiac phenotypes.
OGN induces bone formation in conjunction with TGF-beta-1 or TGF-beta-2. According to the NCBI Gene summary, it induces ectopic bone formation together with transforming growth factor beta and may regulate osteoblast differentiation. It is a secreted protein found in the extracellular matrix.
OGN is the symbol for osteoglycin, also called mimecan, OIF and SLRP3A. The OIF alias and the earlier name osteoglycin (osteoinductive factor) come from its description as an osteoinductive factor. UniProt names the protein Mimecan. Alternative splicing produces multiple transcript variants.
A mouse ortholog, Ogn, is recorded for the human gene. NCBI Gene reports that high expression of the protein may be associated with elevated heart left ventricular mass. Check the datasheet of any product for its validated reactivity.
Other small leucine-rich proteoglycans, TGF-beta pathway proteins and bone-biology markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P20774; product specifications from Assay Genie datasheets.